Allyson M. Maur
Professional Bio
Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.
FDA and EMA Provide Guiding Principles for AI in Drug Development
Password Protected ·